Explanation:
The proper action to validate a diagnosis and administer therapeutic care is esophagogastroduodenoscopy.
Explanation:
The exercise stress test, which is noninvasive, affordable, practical, and sensitive in this type of patient, is the most appropriate initial step in the workup of a patient with recent chest pain.
Explanation:
Erythema nodosum is the name for the rash that seems to be bruised and affects the lower extremities below the knees. It may be caused by an antibiotic. In this clinical situation, each of these signs is present.
Explanation:
Most likely, the patient has vitiligo. It may be an autoimmune disorder, while the real etiology is unknown. There is a genetic component. Progressive skin depigmentation is brought on by the loss of skin melanocytes. On the face, digits, and flexor surfaces, it frequently manifests itself.
Explanation:
The most frequent ERCP consequence is pancreatitis. X-rays are used during the endoscopic retrograde cholangiopancreatography (ERCP) operation to visualize the bile and pancreatic ducts. A gallstone blockage is a common reason for the surgery. To allow the flexible tube to enter the lower structures and introduce dye, the air is introduced through the mouth as the scope is inserted. Of those who receive an ERCP, 3% to 5% develop mild pancreatitis.
Explanation:
Based on the typical signs of gonadotropin insufficiency, weakness, exhaustion, and sexual dysfunction, hypopituitarism is suspected. Hypogonadism is indicated by the lower levels of luteinizing and follicle-stimulating hormones. Along with the lower testosterone levels, these laboratory results point to hypopituitarism.
Explanation:
An acetylcholinesterase inhibitor is a donepezil. Donepezil boosts cholinergic transmission by blocking the enzyme that breaks down acetylcholine, which is deficient in Alzheimer's patients. It can enhance behavior, cognition, and functioning with daily activities. Memantine antagonizes glutamate, galantamine modulates cholinesterase and nicotinic receptor stimulation, and rivastigmine inhibits acetyl/butyrylcholinesterase.